Page last updated: 2024-12-09

1-(2-hydroxyphenyl)-2-(2H-tetrazol-5-yl)ethanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

1-(2-hydroxyphenyl)-2-(2H-tetrazol-5-yl)ethanone is a chemical compound with the molecular formula C9H8N4O2. It is also known as **(2-Hydroxyphenyl)acetyltetrazole** or **(2-Hydroxybenzoyl)tetrazole**.

This compound is important for research due to its potential applications in various fields, including:

**1. Pharmaceutical Research:**

* **Anti-inflammatory Activity:** Studies have shown that (2-Hydroxyphenyl)acetyltetrazole exhibits significant anti-inflammatory activity, potentially acting as a COX-2 inhibitor. This makes it a promising candidate for the development of new anti-inflammatory drugs.
* **Anti-cancer Activity:** Some research suggests that the compound has anti-cancer properties, particularly against certain types of leukemia cells. This warrants further investigation to explore its therapeutic potential.
* **Neuroprotective Activity:** Studies suggest that (2-Hydroxyphenyl)acetyltetrazole might protect neurons from damage caused by oxidative stress, making it relevant for research on neurodegenerative diseases like Alzheimer's and Parkinson's.

**2. Material Science:**

* **Coordination Chemistry:** The tetrazole ring in the molecule can act as a ligand, forming coordination complexes with various metals. This property makes the compound useful in developing new materials with potential applications in catalysis, sensing, and bioimaging.

**3. Organic Synthesis:**

* **Building Block:** Due to its structure and functional groups, (2-Hydroxyphenyl)acetyltetrazole can serve as a valuable building block in organic synthesis, enabling the creation of novel and complex molecules with various potential uses.

**Current Research:**

While (2-Hydroxyphenyl)acetyltetrazole has shown promise in various areas, research is ongoing to:

* **Further elucidate its mechanism of action:** Understanding how the compound interacts with biological systems is crucial for optimizing its therapeutic applications.
* **Develop more potent and selective derivatives:** Researchers are exploring modifications to the molecule to improve its efficacy and target specific biological pathways.
* **Investigate its safety and pharmacokinetic properties:** Before any clinical trials can be conducted, researchers need to establish the safety and effectiveness of the compound in living organisms.

Overall, 1-(2-hydroxyphenyl)-2-(2H-tetrazol-5-yl)ethanone is a fascinating molecule with the potential to revolutionize various fields. Further research is crucial to unlock its full potential and develop safe and effective applications.

Cross-References

ID SourceID
PubMed CID902451
CHEMBL ID1327686
CHEBI ID107399

Synonyms (13)

Synonym
smr000231107
MLS000704799
1-(2-hydroxyphenyl)-2-(1h-tetraazol-5-yl)ethanone
CHEBI:107399
1-(2-hydroxyphenyl)-2-(2h-tetrazol-5-yl)ethanone
HMS2562L20
60723-60-6
CHEMBL1327686
Q27185708
DTXSID40358572
1-(2-hydroxyphenyl)-2-(1h-1,2,3,4-tetrazol-5-yl)ethan-1-one
EN300-6733138
Z1513821069
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aromatic ketoneA ketone in which the carbonyl group is attached to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency28.18380.044717.8581100.0000AID485294
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency5.00000.140911.194039.8107AID2451
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency44.66840.631035.7641100.0000AID504339
huntingtin isoform 2Homo sapiens (human)Potency5.62340.000618.41981,122.0200AID1688
gemininHomo sapiens (human)Potency1.29950.004611.374133.4983AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1145602Antiallergic activity in iv dosed Sprague-Dawley rat assessed as inhibition of egg albumin-induced passive cutaneous anaphylaxis administered immediately prior to egg albumin challenge measured after 30 mins by Evan blue dye leakage assay relative to diso1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Studies on antianaphylactic agents. 5. Synthesis of 3-(1H-tetrazol-5-yl)chromones, a new series of antiallergic substances.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.19 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]